Reforming the World Health Organization’s Essential Medicines List: Essential but Unaffordable
This Viewpoint proposes restructuring the WHO Essential Medicines List to remove consideration of cost and cost-effectiveness from the expert committee reviews of clinical effectiveness, safety, and public health value, and chartering a new framework for pooled global negotiation and procurement of...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2022-11, Vol.328 (18), p.1807-1808 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This Viewpoint proposes restructuring the WHO Essential Medicines List to remove consideration of cost and cost-effectiveness from the expert committee reviews of clinical effectiveness, safety, and public health value, and chartering a new framework for pooled global negotiation and procurement of costly medicines included in the list. |
---|---|
ISSN: | 0098-7484 1538-3598 |
DOI: | 10.1001/jama.2022.19459 |